Product Overview/Feature
![Tsumura Goreisan[17] : 42 sachets(for two weeks)](https://cache.triple-farm.com/npie/itemimg/TF005315_002_01.jpg?v=)
Code：005315-002
Tsumura Goreisan[17] : 42 sachets(for two weeks)
Sale Price：US$32.49
| Warehouse | Japan1 |
|---|---|
| Manufacturer | TSUMURA & CO. |
| Brand | TSUMURA & CO. |
| JAN Code | --- |
| GS1 | --- |
| Ingredient Code | 5200048 |
| Shipping Schedule | about 3 weeks after payment |
Description
Goreisan is indicated for the relief of the following symptoms of those patients with oral dryness and decreased urine volume:Edema, nephrosis, alcoholic hangover, acute gastrointestinal catarrh, diarrhea, nausea, vomiting, dizziness, water retention in the stomach, headache, uremia, heat-stroke, and diabetes mellitus
Presentation
42 sachets
Feature
Granules
Active Ingredients
7.5 g(3sachets for 1day) of TSUMURA Goreisan extract granulescontains 2.0 g of a dried extract of the followingmixed crude drugs.JP Alisma Rhizome 4.0 gJP Atractylodes Lancea Rhizome 3.0 gJP Polyporus Sclerotium 3.0 gJP Poria Sclerotium 3.0 gJP Cinnamon Bark 1.5 g(JP: The Japanese Pharmacopoeia)
Effect/Efficacy
TJ-17 is indicated for the relief of the following symptoms of
those patients with oral dryness and decreased urine volume:
Edema, nephrosis, alcoholic hangover, acute gastrointestinal catarrh, diarrhea, nausea, vomiting, dizziness, water retention in the stomach, headache, uremia, heat-stroke, and diabetes me
Usage/Dosage
The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted ac-cording to the patient's age and body weight, and symptoms.
Cautions
1)When TJ-17 is used, the patient’s “SHO” (constitution/symptoms) should be aken into account. The patient’s progress should be carefully monitored, and if
no improvement in symptoms/findings is observed, continuous treatment should be avoided.
(2)When TJ-17 is coadministered with other Kampo-preparations (Japanese ｔraditional herbal medicines), etc., attention should be paid to the duplication of the contained crude drugs.
Contraindication
TJ-17has not been investigated (drug use investigations, etc.) to determine the incidence of adverse reactions. Therefore, the incidence of adverse reactions is not known.